Alyeska Investment Group, L.P. In8 Bio, Inc. Put Options Transaction History
Alyeska Investment Group, L.P.
- $23.4 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INAB
# of Institutions
29Shares Held
21.7MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX8.6MShares$18.4 Million1.8% of portfolio
-
Franklin Resources Inc San Mateo, CA5.7MShares$12.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$3.86 Million0.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.45MShares$3.1 Million0.13% of portfolio
-
Sigma Planning Corp Ann Arbor, MI701KShares$1.5 Million0.0% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $52.4M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...